Cardio Diagnostics Leverages AI, Genetics, and Epigenetics to Transform Cardiovascular Risk Detection

Cardio Diagnostics Holdings (NASDAQ: CDIO) is gaining attention for its innovative approach to cardiovascular disease detection, as highlighted in a recent article. The company is developing a suite of clinical, population health, and biopharma solutions that leverage artificial intelligence, genetics, and epigenetics to improve prevention, detection, and management of cardiovascular disease.

The article emphasizes the urgent need for more effective tools to identify risk earlier and guide personalized intervention strategies. Cardio Diagnostics' platform integrates genetic and epigenetic biomarkers with AI-driven analytics to provide personalized cardiovascular insights from blood-based testing. The company currently offers two clinical solutions, Epi+Gen CHD and PrecisionCHD, along with population health and biopharma offerings, HeartRisk and CardioInnovate360, respectively. These solutions collectively aim to address cardiovascular disease across multiple stages of care, from early detection and prevention to therapeutic development and population-level risk management.

Cardio Diagnostics is an AI-powered precision cardiovascular medicine company focused on making cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The company was formed to further develop and commercialize clinical tests by leveraging its proprietary AI-driven Integrated Genetic-Epigenetic Engine (Core Technology). This technology is designed to become a leading medical technology for improving prevention, detection, and treatment of cardiovascular disease.

For more details, the full article can be accessed at https://ibn.fm/Nfps9. The latest news and updates relating to CDIO are available in the company's newsroom at https://ibn.fm/CDIO.

Forward-looking statements in this article involve risks and uncertainties, as detailed in the company's SEC filings. Cardio Diagnostics undertakes no duty to update this information unless required by law.